Some additional positive news happened in June 2018, the Food and Drug Administration approved the first CBD-derived drug — Epidiolex, which contains purified CBD — to treat certain childhood seizure syndromes. Very promising findings and many are interested in long term effects. It’s likely that CBD will be used to treat other medical conditions in the near future.
As mentioned above, CBD is no longer considered a Schedule I controlled substance under the Farm Act. However, under the DEA’s definition, it remains on the list. This allows for individual states to create exceptions to the status of CBD, even when cultivated from hemp plants grown legally under the act. It also maintains illegal status for any CBD sourced from plants produced in settings that are not consistent with that Act, or by an unlicensed grower. It is expected that more clarification on the status of CBD will come early this year (2019).